The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Retinoic acid induces proteasome-dependent degradation of retinoic acid receptor α (RAR α ) and oncogenic RAR α fusion proteins
Open accessAbstract
Analyzing the pathways by which retinoic acid (RA) induces promyelocytic leukemia/retinoic acid receptor α (PML/RAR α ) catabolism in acute promyelocytic leukemia (APL), we found that, in addition to caspase-mediated PML/RAR α cleavage, RA triggers degradation of both PML/RAR α and RAR α . Similarly, in non-APL cells, RA directly targeted RAR α and RAR α fusions to the proteasome degradation pathway. Activation of either RAR α or RXR α by specific agonists induced degradation of both proteins. Conversely, a mutation in RAR α that abolishes heterodimer formation and DNA binding, blocked both RAR α and RXR α degradation. Mutations in the RAR α DNA-binding domain or AF-2 transcriptional activation region also impaired RAR α catabolism. Hence, our results link transcriptional activation to receptor catabolism and suggest that transcriptional up-regulation of nuclear receptors by their ligands may be a feedback mechanism allowing sustained target-gene activation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Current protocols in molecular biology
(1988) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(88)90131-4 · Cited by 4,160
Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia
Huang, M., Ye, Y., Chen, Sr., Chai, Jr., Lu, J., Zhoa, L., Gu, L., & Wang, Z. (1988) · Blood · doi:10.1182/blood.v72.2.567.567 · Cited by 2,445
de Thé, H., Lavau, C., Marchio, A., Chomienne, C., Degos, L., & Dejean, A. (1991) · Cell · doi:10.1016/0092-8674(91)90113-d · Cited by 1,343
Self-citationRole of the histone deacetylase complex in acute promyelocytic leukaemia
Lin, R. J., Nagy, L., Inoue, S., Shao, W., Miller, W. H., & Evans, R. M. (1998) · Nature · doi:10.1038/35895 · Cited by 1,062
Identification of a retinoic acid responsive element in the retinoic acid receptor & beta;gene
de The, H., del Mar Vivanco-Ruiz, M., Tiollais, P., Stunnenberg, H., & Dejean, A. (1990) · Nature · doi:10.1038/343177a0 · Cited by 1,006
Grignani, F., De Matteis, S., Nervi, C., Tomassoni, L., Gelmetti, V., Cioce, M., Fanelli, M., Ruthardt, M., Ferrara, F. F., Zamir, I., et al. (1998) · Nature · doi:10.1038/35901 · Cited by 1,004
Chen, G., Zhu, J., Shi, X., Ni, J., Zhong, H., Si, G., Jin, X., Tang, W., Li, X., Xong, S., et al. (1996) · Blood · doi:10.1182/blood.v88.3.1052.1052 · Cited by 864
Self-citationA novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein
Dyck, J. A., Maul, G. G., Miller, W. H., Chen, J. D., Kakizuka, A., & Evans, R. M. (1994) · Cell · doi:10.1016/0092-8674(94)90340-9 · Cited by 785
Muller, S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.1.61 · Cited by 674
Weis, K., Rambaud, S., Lavau, C., Jansen, J., Carvalho, T., Carmo-Fonseca, M., Lamond, A., & Dejean, A. (1994) · Cell · doi:10.1016/0092-8674(94)90341-7 · Cited by 652
Proteasome-dependent degradation of the human estrogen receptor
Nawaz, Z., Lonard, D. M., Dennis, A. P., Smith, C. L., & O’Malley, B. W. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.1858 · Cited by 589
Grignani, F., Ferrucci, P. F., Testa, U., Talamo, G., Fagioli, M., Alcalay, M., Mencarelli, A., Grignani, F., Peschle, C., Nicoletti, I., et al. (1993) · Cell · doi:10.1016/0092-8674(93)80044-f · Cited by 583
Pml is essential for multiple apoptotic pathways
Wang, Z.-G., Ruggero, D., Ronchetti, S., Zhong, S., Gaboli, M., Rivi, R., & Pandolfi, P. P. (1998) · Nature Genetics · doi:10.1038/3073 · Cited by 558
He, L.-Z., Guidez, F., Tribioli, C., Peruzzi, D., Ruthardt, M., Zelent, A., & Pandolfi, P. P. (1998) · Nature Genetics · doi:10.1038/ng0298-126 · Cited by 557
The t(15;17) translocation alters a nuclear body in a retinoic acid-reversible fashion.
Koken, M. H., Puvion-Dutilleul, F., Guillemin, M. C., Viron, A., Linares-Cruz, G., Stuurman, N., de Jong, L., Szostecki, C., Calvo, F., & Chomienne, C. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06356.x · Cited by 499
Self-citationSubstrate Targeting in the Ubiquitin System
Laney, J. D., & Hochstrasser, M. (1999) · Cell · doi:10.1016/s0092-8674(00)80752-7 · Cited by 449
A PMLRAR α transgene initiates murine acute promyelocytic leukemia
Brown, D., Kogan, S., Lagasse, E., Weissman, I., Alcalay, M., Pelicci, P. G., Atwater, S., & Bishop, J. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2551 · Cited by 434
Zhu, J., Koken, M. H. M., Quignon, F., Chelbi-Alix, M. K., Degos, L., Wang, Z. Y., Chen, Z., & de Thé, H. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.3978 · Cited by 427
Self-citationvom Baur, E., Zechel, C., Heery, D., Heine, M. J., Garnier, J. M., Vivat, V., Le Douarin, B., Gronemeyer, H., Chambon, P., & Losson, R. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00339.x · Cited by 399
Muller, A. J., Young, J. C., Pendergast, A. M., Pondel, M., Landau, N. R., Littman, D. R., & Witte, O. N. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.4.1785 · Cited by 377
PML induces a novel caspase-independent death process
Quignon, F., De Bels, F., Koken, M., Feunteun, J., Ameisen, J.-C., & de Thé, H. (1998) · Nature Genetics · doi:10.1038/3068 · Cited by 374
Self-citationMilgröm, E., Thi, L., Atger, M., & Baulieu, É.-É. (1973) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)43455-8 · Cited by 360
Rochette-Egly, C., Adam, S., Rossignol, M., Egly, J.-M., & Chambon, P. (1997) · Cell · doi:10.1016/s0092-8674(00)80317-7 · Cited by 308
Self-citationLallemand-Breitenbach, V., Guillemin, M.-C., Janin, A., Daniel, M.-T., Degos, L., Kogan, S. C., Michael Bishop, J., & de Thé, H. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.7.1043 · Cited by 305
Self-citationGuidez, F., Ivins, S., Zhu, J., Söderström, M., Waxman, S., & Zelent, A. (1998) · Blood · doi:10.1182/blood.v91.8.2634.2634_2634_2642 · Cited by 293
Self-citationPML, a growth suppressor disrupted in acute promyelocytic leukemia.
Mu, Z. M., Chin, K. V., Liu, J. H., Lozano, G., & Chang, K. S. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.10.6858 · Cited by 288
PML protein expression in hematopoietic and acute promyelocytic leukemia cells
Daniel, M., Koken, M., Romagne, O., Barbey, S., Bazarbachi, A., Stadler, M., Guillemin, M., Degos, L., Chomienne, C., & de The, H. (1993) · Blood · doi:10.1182/blood.v82.6.1858.1858 · Cited by 251
Self-citationYoshida, H., Kitamura, K., Tanaka, K., Ōmura, S., Miyazaki, T., Hachiya, T., Ohno, R., & Naoe, T. (1996) · PubMed · Cited by 249
The PML growth-suppressor has an altered expression in human oncogenesis.
Koken, M. H. M., Linares‐Cruz, G., Quignon, F., Viron, A., Chelbi‐Alix, M. K., Sobczak‐Thépot, J., Juhlin, L., Degos, L., Calvo, F. M., & de Thé, H. (1995) · PubMed · Cited by 231
Self-citationRaelson, J., Nervi, C., Rosenauer, A., Benedetti, L., Monczak, Y., Pearson, M., Pelicci, P., & Miller, W. J. (1996) · Blood · doi:10.1182/blood.v88.8.2826.bloodjournal8882826 · Cited by 197
Two distinct actions of retinoid-receptor ligands
Chen, J.-Y., Clifford, J., Zusi, C., Starrett, J., Tortolani, D., Ostrowski, J., Reczek, P. R., Chambon, P., & Gronemeyer, H. (1996) · Nature · doi:10.1038/382819a0 · Cited by 194
Nervi, C., Ferrara, F. F., Fanelli, M., Rippo, M. R., Tomassini, B., Ferrucci, P. F., Ruthardt, M., Gelmetti, V., Gambacorti-Passerini, C. B., Diverio, D., et al. (1998) · PubMed · doi:10.1182/blood.v92.7.2244 · Cited by 169
Giannı̀, M., Koken, M. H. M., Chelbi-Alix, M. K., Benoit, G., Lanotte, M., Chen, Z., & de Thé, H. (1998) · Blood · doi:10.1182/blood.v91.11.4300 · Cited by 164
Self-citationShao, W., Benedetti, L., Lamph, W. W., Nervi, C., & Miller, W. H. (1997) · Blood · doi:10.1182/blood.v89.12.4282 · Cited by 146
Masuyama, H., & MacDonald, P. N. (1998) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19981201)71:3<429::aid-jcb11>3.0.co;2-p · Cited by 127
Phosphorylation of the retinoic acid receptor-alpha by protein kinase A
Rochette-Egly, C. (1995) · Molecular Endocrinology · doi:10.1210/me.9.7.860 · Cited by 124
Self-citationInfluence of a steroid receptor DNA-binding domain on transcriptional regulatory functions.Preprint
Lefstin, J. A., Thomas, J., & Yamamoto, K. R. (1994) · Genes & Development · doi:10.1101/gad.8.23.2842 · Cited by 119
Koken, M. H. M., Reid, A., Quignon, F., Chelbi‐Alix, M. K., Davies, J. M., Kabarowski, J. H. S., Zhu, J., Dong, S., Chen, S., Chen, Z., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.19.10255 · Cited by 117
Self-citationKoken, M. H. M., Daniel, M., Gianni’, M., Zelent, A., Licht, J. D., Buzyn, A., Minard, P., Degos, L., Varet, B. R., & de Thé, H. (1999) · Oncogene · doi:10.1038/sj.onc.1202414 · Cited by 100
Self-citationConstitutive Degradation of PML/RAR Through the Proteasome Pathway Mediates Retinoic Acid Resistance
Fanelli, M., Minucci, S., Gelmetti, V., Nervi, C., Gambacorti-Passerini, C. B., & Pelicci, P. G. (1999) · Blood · doi:10.1182/blood.v93.5.1477 · Cited by 81
All-trans retinoic acid modulates the retinoic acid receptor-alpha in promyelocytic cells.
Chomienne, C., Balitrand, N., Ballerini, P. F., Castaigné, S., de Thé, H., & Degos, L. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115547 · Cited by 76
Retinoic acid and arsenic: towards oncogene-targeted treatments of acute promyelocytic leukaemia
Quignon, F., Chen, Z., & de Thé, H. (1997) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(97)00025-5 · Cited by 41
Self-citation
Cited by
Acute promyelocytic leukemia: from highly fatal to highly curable
Wang, Z.-Y., & Chen, Z. (2008) · Blood · doi:10.1182/blood-2007-07-102798 · Cited by 1,277
Nuclear structure in cancer cells
Zink, D., Fischer, A. H., & Nickerson, J. A. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1430 · Cited by 1,068
Arsenic Trioxide Controls the Fate of the PML-RARα Oncoprotein by Directly Binding PML
Zhang, X.-W., Yan, X.-J., Zhou, Z.-R., Yang, F.-F., Wu, Z.-Y., Sun, H.-B., Liang, W.-X., Song, A.-X., Lallemand-Breitenbach, V., Jeanne, M., et al. (2010) · Science · doi:10.1126/science.1183424 · Cited by 785
Self-citationPhosphorylation of the PTEN Tail Regulates Protein Stability and Function
Vazquez, F., Ramaswamy, S., Nakamura, N., & Sellers, W. R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.14.5010-5018.2000 · Cited by 774
Nuclear retinoid receptors and the transcription of retinoid-target genes
Bastien, J., & Rochette-Egly, C. (2004) · Gene · doi:10.1016/j.gene.2003.12.005 · Cited by 773
Self-citation
Metadata
- Authors
- Zhu, J., Gianni, M., Kopf, E., Honoré, N., Chelbi-Alix, M., Koken, M., Quignon, F., Rochette-Egly, C., & de Thé, H.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1999-12-21
- Volume
- 96
- Issue
- 26
- Pages
- 14807-14812
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1909732837
- Cited by
- 372
- References
- 42
- FWCI
- 5.87
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.